Legal Representation
Attorney
Michele L. Mayberry
USPTO Deadlines
Next Deadline
137 days remaining
NOA E-Mailed - SOU Required
Due Date
May 19, 2026
Extension Available
Until November 19, 2026
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 20, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 19, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 19, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 19, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 2, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 1, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 15, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 1, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 11, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| May 16, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 19, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 16, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 16, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 16, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 16, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 16, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 7, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 7, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Feb 8, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Feb 8, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 8, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 19, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 18, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 18, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 18, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 18, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 18, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 5, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 10, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 23, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 009
Scientific apparatus and instruments, namely, advanced fermentation equipment in the nature of fermentation apparatus for fermentation of biological organisms in biomanufacturing and synthetic biology (syn-bio) processes to produce customized synthetic biology products for use in industry and science for food, ingredients for food, additives for food, nutraceuticals, food supplements, animal feed, pharmaceuticals, cosmetics, biomaterials, enzymes, and as materials used in a wide variety of consumer goods
Class 040
Bioprocessing services, namely, biomanufacturing producing customized synthetic biology products for use in industry and science for food, animal feed, pharmaceuticals, cosmetics, and as materials used in a wide variety of consumer goods for others using biological organisms in the manufacturing process
Class 042
Consulting services in the field of biotechnology; development of new technology in the fields of synthetic biology and industrial biotechnology; development of new technology for others in the fields of synthetic biology and industrial biotechnology; consulting services in the fields of pharmaceutical research and development, pharmaceutical laboratory testing, pharmacogenetics and genetic science; research and development in the pharmaceutical and biotechnology fields
Classification
International Classes
009
040
042